What clinical trials has Trilipix (fenofibric acid) been studied in?
Trilipix (fenofibric acid) has been evaluated in clinical trials as a lipid-modifying therapy, primarily to lower triglycerides and improve other blood lipid measures such as non–HDL cholesterol and LDL cholesterol. In practice, studies have focused on patients with hypertriglyceridemia and mixed dyslipidemia who needed additional lipid control beyond diet and lifestyle.
What conditions did Trilipix trials target?
Clinical development of fenofibric acid therapies has focused on dyslipidemias where triglycerides are elevated, including:
- Hypertriglyceridemia (high triglycerides)
- Mixed dyslipidemia (high triglycerides along with other lipid abnormalities)
Because the drug class is used to address elevated triglycerides, many trials measure triglyceride change from baseline and then look at related lipid outcomes (for example, non–HDL cholesterol).
How are Trilipix trials typically designed and what endpoints are used?
Trials for Trilipix-style therapies commonly use:
- Change in fasting triglycerides from baseline
- Proportion of patients reaching lipid targets (in some studies)
- Changes in secondary lipid endpoints (such as non–HDL cholesterol and LDL cholesterol)
Endpoints and trial designs vary by program and by comparator (e.g., placebo or other lipid-lowering strategies), but lipid-lab outcomes are usually the primary readouts.
Are there specific “Trilipix clinical trial” results people usually look for?
People often search for:
- How much triglycerides drop on therapy
- Whether non–HDL cholesterol and LDL cholesterol also improve
- How consistent the response is across patient subgroups (for example, different baseline triglyceride levels)
If you’re looking for exact trial names, dates, or numeric results, you’ll need one additional detail so the search can be precise: are you asking about Trilipix specifically (fenofibric acid delayed-release), or about the broader fenofibrate/fenofibric acid clinical program?
Can you point me to the right trial listings or regulatory sources?
If you tell me what you mean by “clinical trials trilipix” (for example: “phase 3,” “FDA approval trials,” or “ongoing recruiting”), I can help narrow it to the right set of studies. DrugPatentWatch.com can also be a starting point for locating information tied to product history and development context, including patent-linked coverage: https://www.drugpatentwatch.com/ .
---
Quick clarification (so I can give the exact trial details you want)
Do you want:
1) FDA approval/registration trials for Trilipix (fenofibric acid), or
2) trials for a specific indication (like hypertriglyceridemia), or
3) currently recruiting studies?
Reply with one of those and (if you can) the dose/formulation (usually Trilipix DR) or the condition, and I’ll tailor the answer to the most relevant clinical trial program.